
2028 年亚太地区疣治疗市场预测 - COVID-19 影响和按类型划分的区域分析(寻常疣、生殖器疣、扁平疣等);治疗(物理破坏、免疫调节和化学破坏);最终用户(医院、家庭护理、专科诊所等)
No. of Pages: 148 | Report Code: TIPRE00025053 | Category: Life Sciences
No. of Pages: 148 | Report Code: TIPRE00025053 | Category: Life Sciences
疣是由人乳头瘤病毒(HPV)引起的皮肤生长。 HPV 有 60 多种类型,其中一些容易引起皮肤疣。局部治疗可能会在几周内解决疣问题,并且副作用最小。局部治疗可能并不总是有效。因此,液氮冷冻疗法是一种合适的治疗选择,其治愈率为60%至90%,复发率低于20%至10%。
因此,新产品的开发预计将创造未来几年对疣治疗药物的巨大需求,预计将进一步推动疣治疗市场的发展。
COVID-19 大流行给全球带来了前所未有的挑战。它给世界许多国家的卫生系统带来了巨大压力,并扰乱了包括 HPV 筛查在内的许多服务。 COVID-19 大流行可能会扭转该地区在减少 HPV 负担方面取得的进展。由于经济活动和人口结构的集中,COVID-19 对东北亚的影响是巨大的。尽管疫情阻碍了许多可持续发展目标的进展,甚至逆转了一些成果。该次区域大多数国家的GDP水平相对较低,进一步阻碍了许多医疗保健政策的进展。此外,资源被重新分配给 COVID-19,许多州和地方公共卫生计划已无法维持 COVID-19 之前预防和控制其他传染病的活动水平。有关艾滋病毒、病毒性肝炎、性传播感染和结核病项目的此类负面影响已有报道。人员配备的减少加上诊断能力的下降,导致性传播疾病筛查的短缺,以及由于社交距离要求而进行现场患者护理的能力有限,对市场增长产生了负面影响。
亚太地区的疣治疗市场是预计将从 2021 年的 4.15 亿美元增长到 2028 年的 5.415 亿美元;预计2021年至2028年复合年增长率为3.9%。疣是由多种人乳头瘤病毒(HPV)毒株引起的,不同毒株会导致身体不同部位出现疣。健康人接触疣可能会受到感染。而且,尖锐湿疣的复发率很高。根据国家生物技术信息中心 (NCBI) 的数据,约 30% 的疣病例预计会在感染后的前四个月内消退。 HPV 感染会导致宫颈癌,而宫颈癌是女性第四大常见癌症。根据世界卫生组织 (WHO) 的数据,2018 年记录了约 570,000 例新发宫颈癌病例,低收入国家的患病率很高。因此,HPV 感染率的增加导致疣病例增加,而疣的高复发率正在推动疣治疗市场的增长。
从类型来看,寻常疣细分市场在2020年亚太地区疣治疗市场中占据最大份额。就治疗而言,物理破坏细分市场在2020年亚太疣治疗市场中占据最大份额。在最终用户方面,医院细分市场在2020年亚太疣治疗市场中占据最大份额。
按类型
通过治疗
作者< span>最终用户
按国家/地区
Strategic insights for Asia Pacific Warts Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 415.0 Million |
Market Size by 2028 | US$ 541.5 Million |
Global CAGR (2021 - 2028) | 3.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Warts Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Warts Therapeutics Market is valued at US$ 415.0 Million in 2021, it is projected to reach US$ 541.5 Million by 2028.
As per our report Asia Pacific Warts Therapeutics Market, the market size is valued at US$ 415.0 Million in 2021, projecting it to reach US$ 541.5 Million by 2028. This translates to a CAGR of approximately 3.9% during the forecast period.
The Asia Pacific Warts Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Warts Therapeutics Market report:
The Asia Pacific Warts Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Warts Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Warts Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.